184 related articles for article (PubMed ID: 21149620)
1. Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4.
Lassaux P; Traoré DA; Loisel E; Favier A; Docquier JD; Sohier JS; Laurent C; Bebrone C; Frère JM; Ferrer JL; Galleni M
Antimicrob Agents Chemother; 2011 Mar; 55(3):1248-55. PubMed ID: 21149620
[TBL] [Abstract][Full Text] [Related]
2. Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.
Papagiannitsis CC; Pollini S; De Luca F; Rossolini GM; Docquier JD; Hrabák J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7811-4. PubMed ID: 26369975
[TBL] [Abstract][Full Text] [Related]
3. Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.
Merino M; Pérez-Llarena FJ; Kerff F; Poza M; Mallo S; Rumbo-Feal S; Beceiro A; Juan C; Oliver A; Bou G
J Antimicrob Chemother; 2010 Sep; 65(9):1950-4. PubMed ID: 20624761
[TBL] [Abstract][Full Text] [Related]
4. Structural and computational investigations of VIM-7: insights into the substrate specificity of vim metallo-β-lactamases.
Borra PS; Leiros HK; Ahmad R; Spencer J; Leiros I; Walsh TR; Sundsfjord A; Samuelsen O
J Mol Biol; 2011 Aug; 411(1):174-89. PubMed ID: 21645522
[TBL] [Abstract][Full Text] [Related]
5. Purification and biochemical characterization of the VIM-1 metallo-beta-lactamase.
Franceschini N; Caravelli B; Docquier JD; Galleni M; Frère JM; Amicosante G; Rossolini GM
Antimicrob Agents Chemother; 2000 Nov; 44(11):3003-7. PubMed ID: 11036013
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
Borgianni L; Vandenameele J; Matagne A; Bini L; Bonomo RA; Frère JM; Rossolini GM; Docquier JD
Antimicrob Agents Chemother; 2010 Aug; 54(8):3197-204. PubMed ID: 20498317
[TBL] [Abstract][Full Text] [Related]
7. The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
Palacios AR; Mojica MF; Giannini E; Taracila MA; Bethel CR; Alzari PM; Otero LH; Klinke S; Llarrull LI; Bonomo RA; Vila AJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348667
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases.
Mojica MF; Mahler SG; Bethel CR; Taracila MA; Kosmopoulou M; Papp-Wallace KM; Llarrull LI; Wilson BM; Marshall SH; Wallace CJ; Villegas MV; Harris ME; Vila AJ; Spencer J; Bonomo RA
Biochemistry; 2015 May; 54(20):3183-96. PubMed ID: 25915520
[TBL] [Abstract][Full Text] [Related]
9. A Single Salt Bridge in VIM-20 Increases Protein Stability and Antibiotic Resistance under Low-Zinc Conditions.
Cheng Z; Shurina BA; Bethel CR; Thomas PW; Marshall SH; Thomas CA; Yang K; Kimble RL; Montgomery JS; Orischak MG; Miller CM; Tennenbaum JL; Nix JC; Tierney DL; Fast W; Bonomo RA; Page RC; Crowder MW
mBio; 2019 Nov; 10(6):. PubMed ID: 31744917
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Juan C; Beceiro A; Gutiérrez O; Albertí S; Garau M; Pérez JL; Bou G; Oliver A
Antimicrob Agents Chemother; 2008 Oct; 52(10):3589-96. PubMed ID: 18644957
[TBL] [Abstract][Full Text] [Related]
11. His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7.
Leiros HK; Skagseth S; Edvardsen KS; Lorentzen MS; Bjerga GE; Leiros I; Samuelsen Ø
Antimicrob Agents Chemother; 2014 Aug; 58(8):4826-36. PubMed ID: 24913158
[TBL] [Abstract][Full Text] [Related]
12. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
Walsh F; Bracher S; Turner P; Amyes S
Chemotherapy; 2007; 53(6):407-9. PubMed ID: 17934261
[TBL] [Abstract][Full Text] [Related]
13. Biochemical, mechanistic, and spectroscopic characterization of metallo-β-lactamase VIM-2.
Aitha M; Marts AR; Bergstrom A; Møller AJ; Moritz L; Turner L; Nix JC; Bonomo RA; Page RC; Tierney DL; Crowder MW
Biochemistry; 2014 Nov; 53(46):7321-31. PubMed ID: 25356958
[TBL] [Abstract][Full Text] [Related]
14. Crystal Structure of the Metallo-β-Lactamase GOB in the Periplasmic Dizinc Form Reveals an Unusual Metal Site.
Morán-Barrio J; Lisa MN; Larrieux N; Drusin SI; Viale AM; Moreno DM; Buschiazzo A; Vila AJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):6013-22. PubMed ID: 27458232
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
Marchiaro P; Tomatis PE; Mussi MA; Pasteran F; Viale AM; Limansky AS; Vila AJ
Antimicrob Agents Chemother; 2008 Jun; 52(6):2250-2. PubMed ID: 18362187
[TBL] [Abstract][Full Text] [Related]
16. Role of Residues W228 and Y233 in the Structure and Activity of Metallo-β-Lactamase GIM-1.
Skagseth S; Carlsen TJ; Bjerga GE; Spencer J; Samuelsen Ø; Leiros HK
Antimicrob Agents Chemother; 2016 Feb; 60(2):990-1002. PubMed ID: 26643332
[TBL] [Abstract][Full Text] [Related]
17. Postantibiotic and post-beta-lactamase inhibitor effect of carbapenems combined with EDTA against Pseudomonas aeruginosa strains producing VIM-metallo beta-lactamases.
Bedenić B; Vranes J; Sviben M; Beader N; Kalenić S
Chemotherapy; 2008; 54(3):188-93. PubMed ID: 18560225
[TBL] [Abstract][Full Text] [Related]
18. VIM-2 beta-lactamase in Pseudomonas aeruginosa isolates from Zagreb, Croatia.
Bosnjak Z; Bedenić B; Mazzariol A; Jarza-Davila N; Suto S; Kalenić S
Scand J Infect Dis; 2010 Mar; 42(3):193-7. PubMed ID: 20001226
[TBL] [Abstract][Full Text] [Related]
19. Kinetic, Thermodynamic, and Crystallographic Studies of 2-Triazolylthioacetamides as Verona Integron-Encoded Metallo-β-Lactamase 2 (VIM-2) Inhibitor.
Xiang Y; Zhang YJ; Ge Y; Zhou Y; Chen C; Wahlgren WY; Tan X; Chen X; Yang KW
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906402
[TBL] [Abstract][Full Text] [Related]
20. Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1.
Wachino J; Yamaguchi Y; Mori S; Jin W; Kimura K; Kurosaki H; Arakawa Y
Antimicrob Agents Chemother; 2016 Jul; 60(7):4274-82. PubMed ID: 27161644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
